About
Technology
Issues
FAQ
Links
Official Page
An analysis of IL-36 signature genes and individuals with
IL1RL2
knockout mutations validates IL-36 as a psoriasis therapeutic target
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.